Erik Ostrowski - 08 Dec 2022 Form 4 Insider Report for AVROBIO, Inc. (TECX)

Role
Chief Financial Officer
Signature
/s/ Steven Avruch, Attorney-in-Fact for Erik Ostrowski
Issuer symbol
TECX
Transactions as of
08 Dec 2022
Net transactions value
$0
Form type
4
Filing time
09 Dec 2022, 16:29:03 UTC
Previous filing
04 Feb 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +221,000 $0.000000 221,000 08 Dec 2022 Common Stock 221,000 $0.7900 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares shall vest and become exercisable on the first anniversary of the grant date, and the remaining 50% shall vest in equal monthly installments thereafter over a one-year period.